C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/54 (2006.01) A61K 38/45 (2006.01) A61P 3/10 (2006.01) C12N 9/12 (2006.01) C12Q 1/48 (2006.01) C12Q 1/68 (2006.01) G01N 33/566 (2006.01)
Patent
CA 2680946
The invention relates to isolated nucleic acid molecules and to host cells comprising such nucleic acid molecules. Moreover, the invention relates to a polypeptide having PIM-3 activity and having a definite amino acid sequence, as well as to the use of PIM-3 as a screening agent for identifying anti-type 2 diabetes mellitus drugs and for preparing a medicament for the treatment of insulin resistance or type 2 diabetes mellitus.
Korn Marcus Hermann
Mueller Guenter
Schneider Rudolf
Tschank Georg
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Sanofi-Aventis Deutschland Gmbh
LandOfFree
Pim-3 kinase as a target for type 2 diabetes mellitus does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pim-3 kinase as a target for type 2 diabetes mellitus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pim-3 kinase as a target for type 2 diabetes mellitus will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2060658